1. Home
  2. PHVS vs HEPS Comparison

PHVS vs HEPS Comparison

Compare PHVS & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • HEPS
  • Stock Information
  • Founded
  • PHVS 2015
  • HEPS 2000
  • Country
  • PHVS Netherlands
  • HEPS Turkey
  • Employees
  • PHVS N/A
  • HEPS N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • HEPS Catalog/Specialty Distribution
  • Sector
  • PHVS Health Care
  • HEPS Consumer Discretionary
  • Exchange
  • PHVS Nasdaq
  • HEPS Nasdaq
  • Market Cap
  • PHVS 1.0B
  • HEPS 1.0B
  • IPO Year
  • PHVS 2021
  • HEPS 2021
  • Fundamental
  • Price
  • PHVS $19.18
  • HEPS $3.39
  • Analyst Decision
  • PHVS Strong Buy
  • HEPS
  • Analyst Count
  • PHVS 5
  • HEPS 0
  • Target Price
  • PHVS $40.60
  • HEPS N/A
  • AVG Volume (30 Days)
  • PHVS 97.7K
  • HEPS 696.0K
  • Earning Date
  • PHVS 11-13-2024
  • HEPS 12-10-2024
  • Dividend Yield
  • PHVS N/A
  • HEPS N/A
  • EPS Growth
  • PHVS N/A
  • HEPS N/A
  • EPS
  • PHVS N/A
  • HEPS N/A
  • Revenue
  • PHVS N/A
  • HEPS $1,167,077,294.00
  • Revenue This Year
  • PHVS N/A
  • HEPS $43.98
  • Revenue Next Year
  • PHVS N/A
  • HEPS $41.13
  • P/E Ratio
  • PHVS N/A
  • HEPS N/A
  • Revenue Growth
  • PHVS N/A
  • HEPS 82.39
  • 52 Week Low
  • PHVS $15.37
  • HEPS $1.25
  • 52 Week High
  • PHVS $33.00
  • HEPS $4.05
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 46.34
  • HEPS 62.00
  • Support Level
  • PHVS $18.32
  • HEPS $3.07
  • Resistance Level
  • PHVS $20.00
  • HEPS $3.45
  • Average True Range (ATR)
  • PHVS 1.10
  • HEPS 0.19
  • MACD
  • PHVS 0.11
  • HEPS 0.02
  • Stochastic Oscillator
  • PHVS 51.13
  • HEPS 88.64

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

About HEPS D-Market Electronic Services & Trading

D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues, and other revenues.

Share on Social Networks: